HCPCS code M0301
Fabric wrapping of abdominal aneurysm
What M0301 means
M0301 (Fabric wrapping of aneurysm) belongs to the HCPCS Level II M series (Medical Services). Its Medicare coverage status is Non-covered by Medicare. This item or service is not covered by Medicare.
Part B pricing: Service not separately priced by Part B (e.g., services not covered, bundled, used by part a only, etc.).
Code details
- Short description
- Fabric wrapping of aneurysm
- Coverage code
- M = Non-covered by Medicare
- Pricing indicator
- 00 = Service not separately priced by Part B (e.g., services not covered, bundled, used by part a only, etc.)
- Multiple pricing indicator
- 9 = Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established(pricing indicator is '99')
- Type of service
- 2 = Surgery
- Action code
- N = No maintenance for this code
- Action effective date
- January 01, 2004
- Code added date
- January 01, 1986
- Data year
- 2026
Questions about M0301
What is HCPCS code M0301?
HCPCS code M0301 is a Level II code in the M series (Medical Services). Its full description is: "Fabric wrapping of abdominal aneurysm"
Is M0301 a CPT code?
No. M0301 is a HCPCS Level II code maintained by CMS, not a CPT (Level I) code from the American Medical Association. People often search for it as a CPT code because both code sets are reported on the same claims.
Does Medicare cover HCPCS code M0301?
The Medicare coverage code for M0301 is "Non-covered by Medicare". This item or service is not covered by Medicare.
When was HCPCS code M0301 added?
M0301 was added to the HCPCS code set on January 01, 1986. The most recent action on it (No maintenance for this code) took effect on January 01, 2004.
Nearby M codes
All M codes- M0247Intravenous infusion, sotrovimab, includes infusion and post administration monitoring
- M0248Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
- M0249Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
- M0250Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
- M0300Iv chelation therapy (chemical endarterectomy)
- M1000Pain screened as moderate to severe
- M1001Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician
- M1002Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given
- M1003Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
- M1004Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)